Clincosm LogoSign in Get a demo

stage iv prostate cancer ajcc v8

Showing 26 - 49 of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma, Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8 Trial in San Francisco (Angiogram,

Recruiting
  • Prostate Adenocarcinoma
  • +9 more
  • Angiogram
  • +3 more
  • San Francisco, California
    University of California San Francisco
Aug 5, 2022

Metastatic Prostate Carcinoma, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8 Trial (Patient Navigation,

Not yet recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Patient Navigation
  • +3 more
  • (no location specified)
Aug 2, 2022

Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial in Buffalo

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 27, 2022

Screening for Prostate Cancer, GIFTS Study

Enrolling by invitation
  • Metastatic Prostate Carcinoma
  • +2 more
  • Questionnaire
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 22, 2022

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Houston (Computed

Not yet recruiting
  • Metastatic Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate

Suspended
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 27, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma

Recruiting
  • Bladder Small Cell Neuroendocrine Carcinoma
  • +16 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 23, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • San Francisco, California
    University of California San Francisco
Feb 27, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Salt Lake

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Atezolizumab
  • Cabozantinib S-malate
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Mar 11, 2022

Genetic Testing for Men With Metastatic Prostate Cancer

Recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Biospecimen Collection
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 9, 2022

Biochemically Recurrent Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • +6 more
  • Computed Tomography
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 7, 2022

Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston

Recruiting
  • Aggressive Variant Prostate Carcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 10, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial (Pharmacotherapy

Not yet recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Pharmacotherapy Discontinuation
  • +3 more
  • (no location specified)
Feb 11, 2022

Pharmacogenomics Testing in Directing Optimal Use of Supportive

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +45 more
  • Biospecimen Collection
  • +3 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Feb 3, 2022

Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma Trial

Recruiting
  • Aggressive Variant Prostate Carcinoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Bone Trial in

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +17 more
  • Cryosurgery
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 29, 2021

Localized Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Jacksonville

Recruiting
  • Localized Prostate Carcinoma
  • +4 more
  • Cholecalciferol
  • Quality-of-Life Assessment
  • Jacksonville, Florida
    Mayo Clinic in Florida
Dec 1, 2021

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Mexico, United

Recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Gilbert, Arizona
  • +301 more
Nov 8, 2021

Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Los Angeles

Completed
  • Biochemically Recurrent Prostate Carcinoma
  • +8 more
  • Computed Tomography
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 29, 2021

Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • +4 more
  • Educational Intervention
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 13, 2021

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue

Withdrawn
  • Castration Levels of Testosterone
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 31, 2021

Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Oligometastatic Prostate Carcinoma Trial in Houston

Withdrawn
  • Biochemically Recurrent Prostate Carcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 14, 2021